Notice of Results

RNS Number : 6964J
EKF Diagnostics Holdings PLC
21 August 2019
 

 

EKF Diagnostics Holdings plc

("EKF", the "Company")

 

Notice of results

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that it will release its interim results for the six months ended 30 June 2019 on Tuesday 10 September 2019.

 

Investor briefing

A briefing for all investors will take place on Tuesday 10 September 2019 at the Brand Exchange, 3 Birchin Lane, EC3V 9BW from 5.30pm for a 5.45pm start and will be followed by refreshments. If you would like to register, please contact Walbrook PR on 020 7933 8780 or email ekf@walbrookpr.com

 

 

Enquiries:

 

EKF Diagnostics Holdings plc 

www.ekfdiagnostics.com

Christopher Mills, Non-Executive Chairman

Tel: 029 2071 0570

Julian Baines, CEO 


Richard Evans, FD & COO




N+1 Singer (Nomad & Broker)

Tel: 020 7496 3000

Aubrey Powell / Lauren Kettle / George Tzimas (Corporate Finance)

Tom Salvesen (Corporate Broking)




Walbrook PR Limited                                                                           Tel: 020 7933 8780 or ekf@walbrookpr.com 

Paul McManus/ Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303

 



 

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)

EKF is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analyzers in regular use across more than 100 countries. EKF specializes in developing tests for use in anemia and diabetes diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analyzers.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORDMGZRVGKGLZM
UK 100

Latest directors dealings